All NEC-like G3NET patients developed rapid tumor evolution with significant enlargement of liver metastases and/or occurrence of new lesions in a short period of time, along with deterioration of the clinical condition, an elevation of serum transaminases and increase of circulating tumor markers such as chromograninA and/or NSE. The gene discussed is ENO2; the disease is neuroendocrine carcinoma.